Elanco Animal Health Incorporated (NYSE:ELAN) went down by -0.24% from its latest closing price when compared to the 1-year high value of $32.66 and move down -12.39%, while ELAN stocks collected 5.98% of gains with the last five trading sessions. Press Release reported on 08/12/20 that Dr. Marijn Dekkers Joins AgBiome As a Strategic Advisor
Elanco Animal Health Incorporated (NYSE:ELAN) Worth an Investment?
Elanco Animal Health Incorporated (NYSE:ELAN) 10 of the analysts out of 15 who provided ratings for Elanco Animal Health Incorporated stocks as a “buy” while 0 as overweight, 5 rated it as hold and 0 as sell. The average price we get from analysts is $27.94 which is -$2.63 below current price. ELAN currently has a short float of 7.58% and public float of 324.67M with average trading volume of 4.56M shares.
ELAN Market Performance
ELAN stocks went up by 5.98% for the week, with the monthly jump of 22.98% and a quarterly performance of 30.49%, while its annual performance rate touched 11.68%. The simple moving average for the period of the last 20 days is 11.46% for ELAN stocks with the simple moving average of 15.83% for the last 200 days.
Analysts’ Opinion on Elanco Animal Health Incorporated (NYSE:ELAN)
Many brokerage firms have already submitted their reports for ELAN stocks, with Morgan Stanley repeating the rating for ELAN shares by setting it to “Overweight”. The predicted price for ELAN socks in the upcoming period according to Morgan Stanley is $31 based on the research report published on August 20, 2020.
Credit Suisse, on the other hand, stated in their research note that they expect to see ELAN stock at the price of $27. The rating they have provided for ELAN stocks is “Neutral” according to the report published on August 13, 2020.
Goldman gave “Buy” rating to ELAN stocks, setting the target price at $26.50 in the report published on August 4, 2020.
ELAN Stocks 21.96% Far from 50 Day Moving Average
After a stumble in the market that brought ELAN to its low price for the period of the last 52 weeks, Elanco Animal Health Incorporated was unable to take a rebound, for now settling with -11.02% of loss for the given period.
The stock volatility was left at 3.68%, however, within the period of a single month, the volatility rate increased by 3.24%, while the shares surge at the distance of +24.67% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +30.55% upper at the present time.
In the course of the last 5 trading sessions, ELAN went up by +5.98%, which changed the moving average for the period of 200 days to the total of +11.77% of gains for the stock in comparison to the 20-day moving average settled at $26.36. In addition, Elanco Animal Health Incorporated saw -1.32% in overturn over the period of a single year with a tendency to cut further losses.
ELAN Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Elanco Animal Health Incorporated (ELAN), starting from HOOVER R DAVID, who bought 5,000 shares at the price of $28.62 back on Aug 28. After this action, Rushing now owns 45,000 shares of Elanco Animal Health Incorporated, valued at $143,100 with the latest closing price.
HOOVER R DAVID, the See Remarks of Elanco Animal Health Incorporated, bought 5,000 shares at the value of $28.24 during a trade that took place back on Aug 27, which means that HOOVER R DAVID is holding 36,075 shares at the value of $141,200 based on the most recent closing price.
ELAN Stock Fundamentals
The current profitability levels are settled at +12.05 for the present operating margin and +45.60 for gross margin. The net margin for Elanco Animal Health Incorporated stands at +2.21. Total capital return value is set at 4.73, while invested capital returns managed to touch 0.87. Equity return holds the value -1.70%, with -1.10% for asset returns.
Based on Elanco Animal Health Incorporated (ELAN), the company’s capital structure generated 44.00 points for debt to equity in total, while total debt to capital is set at the value of 30.55. Total debt to assets is settled at the value of 27.16 with long-term debt to equity ratio rests at 4.69 and long-term debt to capital is 43.13.
The value for Enterprise to Sales is 4.23 with debt to enterprise value settled at 0.19. The receivables turnover for Elanco Animal Health Incorporated is 3.84 with the total asset turnover at the value of 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.90.